BizJournals Portfolio

Codexis, Inc.

Company Information

200 Penobscot Dr
Redwood City, CA
United States
Phone: (650) 421-8100
Fax: (650) 421-8102

Alan Shaw

codexis.com

Industry: Healthcare


Overview

We are a leading developer of proprietary biocatalysts that we believe have the potential to revolutionize chemistry-based manufacturing processes across a variety of industries. We have focused our biocatalyst development efforts on large and rapidly growing markets, including pharmaceuticals and biofuels. We have used our technology platform to enable biocatalyst-based commercial scale drug manufacturing processes and delivered biocatalysts and drug products to some of the worlds leading pharmaceutical companies. In addition to our commercial success in the pharmaceutical industry, we have a research collaboration with Shell to apply our technology platform to the biofuels market. We are also pursuing funded collaborations in several other bioindustrial markets, including carbon management, water treatment and chemicals. Biocatalysts are enzymes or microbes that catalyze chemical reactions that can enable the production of products used in everyday life. Our proprietary technology platform allows us to rapidly evolve and optimize biocatalysts to perform specific and desired chemical reactions for commercial scale industrial applications. We believe we can use our technology platform to improve industrially relevant characteristics of any biocatalyst, enabling manufacturing processes that are faster, less complex, less capital intensive and lower cost than conventional chemistry-based processes. ...

Corporate Structure

CHIEF EXECUTIVE OFFICER

Alan Shaw

TOP EXECUTIVES

Davinder Singh     
Thomas R. Baruch      Director
Jim Lalonde      Head of Biocatalysis and Chemical Development, Codexis
Tassos Gianakakos      Vice President of Business Development
Gerhard N. Mayr      Board of Directors
Robert Breuil      CFO & Senior Vice President
Jim Gable      Observor
Pascal Duenkelmann      Co-Managing Director, Julich Chiral Solutions
David Walshaw      Vice President, Operations
Patrick G. Enright      Board of Directors
Lawrence W. Briscoe     
John Grate      CTO & Senior Vice President, Technology & Innovation
Douglas Sheehy      General Counsel
William Haseltine      Board of Directors
Bernard J Kelley      Board of Directors
Michael Knauf      Vice President and General Manager, Bioindustrials
Andrea Danforth      Vice President, Human Resources
Peter Seufer-Wasserthal      Vice President and General Manager, Pharma Services
Joseph Sarret      Vice President, Corporate Development
Daniel Wang      Board of Directors
Davinder Singh Brar      Board of Directors
Thomas Daussmann      Vice President and Managing Director, Codexis Laboratories Singapore Pte. Ltd.
David Rozzell      Vice President, Enzyme Products and Services, Pharma Services Group
Lynn Marcus-Wyner      Vice President, Intellectual Property
Nicholas Green      President, Pharmaceuticals
Russell J. Howard      Board of Directors
Bruce A Pasternack      Board of Directors
Dennis P. Wolf      Board of Directors
Frances Arnold      Board of Directors
Codexis Bioindustrials     
Bill Rothwell      Board of Directors
David Anton      Vice President, Bioindustrials Research & Development